TP53 and neoplasm: For example, PTE can inhibit tumor growth by targeting estrogen receptors, fighting drug resistance [37,38], and inducing apoptosis through the p53/cyclin E1 [39], Bcl-2/caspase-3/caspase-9 [40], and caspase-8 signaling pathways [41].